Article
Mice with an Oncogenic HRAS Mutation are Resistant to High-Fat Diet-Induced Obesity and Exhibit Impaired Hepatic Energy Homeostasis.
EBioMedicine - 1 Jan 2018
Oba Daiju, Inoue Shin-Ichi, Miyagawa-Tomita Sachiko, Nakashima Yasumi, Niihori Tetsuya, Yamaguchi Seiji, Matsubara Yoichi, Aoki Yoko
Abstract excerpt
Costello syndrome is a "RASopathy" that is characterized by growth retardation, dysmorphic facial appearance, hypertrophic cardiomyopathy and tumor predisposition. >80% of patients with Costello syndrome harbor a heterozygous germline G12S mutation in HRAS. Altered metabolic regulation has been suspected because patients with Costello syndrome exhibit hypoketotic hypoglycemia and increased resting energy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
